Chun Wai Lee

Title: Innovations of Chun Wai Lee in Automated Tissue Dissection

Introduction

Chun Wai Lee is an accomplished inventor based in El Cerrito, CA. He has made significant contributions to the field of biomedical technology, particularly in the area of tissue processing. His innovative work has led to the development of a unique system that enhances the efficiency of tissue dissection.

Latest Patents

Chun Wai Lee holds a patent for "Systems and methods for pre-analytical substrate processing." This patent describes an Automated Tissue Dissection (ATD) System. The ATD system is designed to perform dissections on a substrate based on digital or pen marks made by pathologists. It utilizes non-contact and mechanical methods to extract Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples. The system focuses on saving only the regions of interest (ROIs) while effectively removing or decomposing nucleic acid content in the regions of no interest (RONI). This innovative approach allows for the collection of all tissue samples from a standard microscope substrate into a designated container.

Career Highlights

Chun Wai Lee is currently employed at Genomic Health, Inc., where he continues to advance his research and development efforts. His work at Genomic Health has positioned him as a key player in the field of genomic medicine, contributing to the improvement of diagnostic processes.

Collaborations

Chun Wai Lee collaborates with talented professionals in his field, including Hubert Yeung and Amy Lee Hsieh Yuan. Their combined expertise fosters an environment of innovation and progress in tissue processing technologies.

Conclusion

Chun Wai Lee's contributions to the field of automated tissue dissection exemplify the impact of innovative thinking in biomedical technology. His patent and ongoing work at Genomic Health, Inc. highlight the importance of advancements in pre-analytical processes for improved patient outcomes.